Guangdong Raynovent Biotech Co., Ltd
Clinical trials sponsored by Guangdong Raynovent Biotech Co., Ltd, explained in plain language.
-
New flu pill for kids shows promise in early trial
Symptom relief OngoingThis study tests a new medicine called ZSP1273 in children aged 2 to 11 who have influenza A. The goal is to see if it can shorten flu symptoms and is safe. About 119 children in China will take either ZSP1273 or the standard flu drug oseltamivir.
Phase: PHASE3 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New flu pill shows promise for teens in Late-Stage trial
Symptom relief OngoingThis phase 3 trial tests whether the experimental drug ZSP1273 can shorten flu symptoms in teenagers aged 12-17 with uncomplicated influenza A. About 157 participants in China will receive either the drug or a placebo. The main goal is to see how quickly symptoms like cough, feve…
Phase: PHASE3 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Obesity drug RAY1225 put through drug interaction tests
Knowledge-focused OngoingThis early-stage study checks if a new obesity drug, RAY1225, changes how the body processes common medicines like warfarin, atorvastatin, metformin, and digoxin. About 32 healthy adults will take RAY1225 along with these drugs to measure blood levels and watch for side effects. …
Phase: PHASE1 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC